Author:
Hans P.,Brichant J. F.,Longerstay E.,Damas F.,Remacle J. M.
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Reference10 articles.
1. Holaday JW, Malcoln DS (1988) Endogenous opioids and other peptides: evidence for their clinical relevance in shock and CNS injury. In: Chernow B (ed) The pharmacologic approach to the critically ill patient, 2nd edn. Williams and Wilkins, Baltimore, pp 718–732
2. Baskin DS, Hosobuchi Y (1981) Naloxone reversal of ischaemic neurologic deficits in man. Lancet II:272–275
3. Benzel EC, Hadden TA, Nossaman BD, Lancon J, Kesterson L (1990) Does sufentanil exacerbate marginal neurological dysfunction? J Neurosurg Anesth 2:50–52
4. Adams HP Jr, Olinger ChP, Barson WG et al (1986) A dose escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia. Stroke 17:404–409
5. Krechel SW, Orr RM, Comper NB, Gufta N, Eggers GWN Jr (1989) Naloxone: report of a beneficial side effect. J Neurosurg Anesth 1:346–351
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献